An open-label 16-week study of liraglutide in adolescents with obesity post-sleeve gastrectomy.

Anna ZennoEjike E NwosuSyeda Z FatimaEvan P NadlerNazrat M MirzaSheila M BradySara A TurnerShanna B YangJulia LazarevaJennifer A Te-VasquezKong Y ChenStephanie T Chung Jack A Yanovski

Published in: Pediatric obesity (2024)

Liraglutide treatment was feasible and associated with a BMI reduction of 4.3% in adolescents who had previously undergone SG, quantitatively similar to results obtained in adolescents with obesity who have not undergone MBS.

Keyphrases

young adults
physical activity
insulin resistance
metabolic syndrome
weight gain
weight loss
type diabetes
high fat diet induced
body mass index
adipose tissue
clinical trial
combination therapy